Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paricalcitol in IgA Nephropathy
NCT00599963Phase 3Withdrawn
- Sponsor
- The Chinese University of Hong Kong
- Start
- Jan 2008
- Primary completion
- Oct 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of paricalcitol in IgA nephropathy (IgAN), sponsored by The Chinese University of Hong Kong. Planned start Jan 2008; status: withdrawn.
02
Drugs
paricalcitol
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on NCT00599963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00599963.